Mark Quinlivan

Summary

Publications

  1. ncbi request reprint The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation
    Mark Quinlivan
    Department of Medical Microbiology, School of Medicine, Queen Mary College, London, United Kingdom
    J Infect Dis 186:888-94. 2002
  2. ncbi request reprint Molecular and therapeutic aspects of varicella-zoster virus infection
    Mark Quinlivan
    Skin Virus Laboratory, Institute of Cell and Molecular Science, 4 Newark Street, Whitechapel, London, E1 28E, UK
    Expert Rev Mol Med 7:1-24. 2005
  3. ncbi request reprint Molecular studies of Varicella zoster virus
    Mark Quinlivan
    Centre for Infectious Diseases, Institute for Cell and Molecular Science, 4 Newark Street, Whitechapel, London, E1 2AT, UK
    Rev Med Virol 16:225-50. 2006
  4. ncbi request reprint Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?
    Yusri A Taha
    Skin Virus Laboratory, Centre for Cutaneous Research, St Bartholomew s and the Royal London School of Medicine and Dentistry, Queen Mary College, London, United Kingdom
    J Med Virol 73:631-5. 2004
  5. ncbi request reprint An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus
    Mark Quinlivan
    Skin Virus Laboratory, Institute of Cell and Molecular Medicine, 25 29 Ashfield Street, White Chapel, London E1 1BB, United Kingdom
    J Med Virol 75:174-80. 2005
  6. ncbi request reprint DNA sequence variability in Oka vaccine isolates
    Judith Breuer
    J Infect Dis 196:801-2; author reply 802-3. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation
    Mark Quinlivan
    Department of Medical Microbiology, School of Medicine, Queen Mary College, London, United Kingdom
    J Infect Dis 186:888-94. 2002
    ..We used the BglI site to examine both the spread of type A viruses in the United Kingdom and the patterns of VZV infections within persons from different ethnic groups who grew up in the United Kingdom or abroad...
  2. ncbi request reprint Molecular and therapeutic aspects of varicella-zoster virus infection
    Mark Quinlivan
    Skin Virus Laboratory, Institute of Cell and Molecular Science, 4 Newark Street, Whitechapel, London, E1 28E, UK
    Expert Rev Mol Med 7:1-24. 2005
    ..In addition, VZV has become the first human herpes virus for which a live attenuated vaccine has been developed...
  3. ncbi request reprint Molecular studies of Varicella zoster virus
    Mark Quinlivan
    Centre for Infectious Diseases, Institute for Cell and Molecular Science, 4 Newark Street, Whitechapel, London, E1 2AT, UK
    Rev Med Virol 16:225-50. 2006
    ..In addition, a rat model has been developed and successfully used to uncover which viral proteins are important for both the establishment and maintenance of latent VZV infection...
  4. ncbi request reprint Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?
    Yusri A Taha
    Skin Virus Laboratory, Centre for Cutaneous Research, St Bartholomew s and the Royal London School of Medicine and Dentistry, Queen Mary College, London, United Kingdom
    J Med Virol 73:631-5. 2004
    ..No VZV gE mutant (MSP/MSP-like) was detected. Overall, PCR was found to be the most sensitive method of confirming VZV infection. False negative VZV immunofluorescence results are unlikely to be due to virus variants...
  5. ncbi request reprint An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus
    Mark Quinlivan
    Skin Virus Laboratory, Institute of Cell and Molecular Medicine, 25 29 Ashfield Street, White Chapel, London E1 1BB, United Kingdom
    J Med Virol 75:174-80. 2005
    ..These sites are also present variably in the vaccine viruses causing rashes following vaccination, and are therefore unreliable markers for differentiating vOka and wild type VZV strains...
  6. ncbi request reprint DNA sequence variability in Oka vaccine isolates
    Judith Breuer
    J Infect Dis 196:801-2; author reply 802-3. 2007